| The consolidation of new but not reactivated memory requires hippocampal C/EBPβ SM Taubenfeld, MH Milekic, B Monti, CM Alberini Nature neuroscience 4 (8), 813-818, 2001 | 543 | 2001 |
| Microglia and neuroprotection: from in vitro studies to therapeutic applications E Polazzi, B Monti Progress in neurobiology 92 (3), 293-315, 2010 | 334 | 2010 |
| Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection B Monti, E Polazzi, A Contestabile Current molecular pharmacology 2 (1), 95-109, 2009 | 293 | 2009 |
| Valproic acid is neuroprotective in the rotenone rat model of Parkinson’s disease: involvement of α-synuclein B Monti, V Gatta, F Piretti, SS Raffaelli, M Virgili, A Contestabile Neurotoxicity research 17, 130-141, 2010 | 219 | 2010 |
| Fornix-dependent induction of hippocampal CCAAT enhancer-binding protein β and δ co-localizes with phosphorylated cAMP response element-binding protein and accompanies long … SM Taubenfeld, KA Wiig, B Monti, B Dolan, G Pollonini, CM Alberini Journal of Neuroscience 21 (1), 84-91, 2001 | 216 | 2001 |
| Multitarget drug design strategy: quinone–tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects E Nepovimova, E Uliassi, J Korabecny, LE Pena-Altamira, S Samez, ... Journal of medicinal chemistry 57 (20), 8576-8589, 2014 | 190 | 2014 |
| Multitarget drug discovery for Alzheimer's disease: triazinones as BACE‐1 and GSK‐3β inhibitors F Prati, A De Simone, P Bisignano, A Armirotti, M Summa, D Pizzirani, ... Angewandte Chemie 127 (5), 1598-1602, 2015 | 155 | 2015 |
| Subchronic rolipram delivery activates hippocampal CREB and arc, enhances retention and slows down extinction of conditioned fear B Monti, C Berteotti, A Contestabile Neuropsychopharmacology 31 (2), 278-286, 2006 | 135 | 2006 |
| Brain nitric oxide and its dual role in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches A Contestabile, B Monti, A Contestabile, E Ciani Current medicinal chemistry 10 (20), 2147-2174, 2003 | 124 | 2003 |
| Tau-centric multitarget approach for Alzheimer’s disease: development of first-in-class dual glycogen synthase kinase 3β and tau-aggregation inhibitors A Gandini, M Bartolini, D Tedesco, L Martinez-Gonzalez, C Roca, ... Journal of medicinal chemistry 61 (17), 7640-7656, 2018 | 115 | 2018 |
| Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease J Jeřábek, E Uliassi, L Guidotti, J Korábečný, O Soukup, V Sepsova, ... European Journal of Medicinal Chemistry 127, 250-262, 2017 | 114 | 2017 |
| Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum B Monti, A Contestabile European Journal of Neuroscience 12 (9), 3117-3123, 2000 | 105 | 2000 |
| Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease K Chalupova, J Korabecny, M Bartolini, B Monti, D Lamba, R Caliandro, ... European journal of medicinal chemistry 168, 491-514, 2019 | 103 | 2019 |
| Dysregulation of memory‐related proteins in the hippocampus of aged rats and their relation with cognitive impairment B Monti, C Berteotti, A Contestabile Hippocampus 15 (8), 1041-1049, 2005 | 93 | 2005 |
| Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids M Benchekroun, M Bartolini, J Egea, A Romero, E Soriano, M Pudlo, ... ChemMedChem 10 (3), 523-539, 2015 | 86 | 2015 |
| Alpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death B Monti, E Polazzi, L Batti, C Crochemore, M Virgili, A Contestabile Journal of neurochemistry 103 (2), 518-530, 2007 | 82 | 2007 |
| 3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease F Prati, A De Simone, A Armirotti, M Summa, D Pizzirani, R Scarpelli, ... ACS chemical neuroscience 6 (10), 1665-1682, 2015 | 76 | 2015 |
| Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation E Pena-Altamira, F Prati, F Massenzio, M Virgili, A Contestabile, ... Expert opinion on therapeutic targets 20 (5), 627-640, 2016 | 75 | 2016 |
| New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents JM Roldan-Pena, D Alejandre-Ramos, O Lopez, I Maya, I Lagunes, ... European journal of medicinal chemistry 138, 761-773, 2017 | 72 | 2017 |
| NMDA receptor‐dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development B Monti, L Marri, A Contestabile European Journal of Neuroscience 16 (8), 1490-1498, 2002 | 72 | 2002 |
Antonio ContestabileUniversity of BolognaVerified email at unibo.it
